The Global Supplement Business Report is your guide to understanding the complex ways inflation is shaping supplement markets across 22 countries and regions worldwide. This year’s report delves into why the U.S. and Western Europe are experiencing very different outcomes as inflation rates ease.
While the U.S. is projected to see supplement sales grow from 4.4% in 2023 to 4.9% in 2024, Western Europe tells a different story: despite inflation dropping to 1.7%, market growth is also slowing, falling from 6.4% to 4.9% in 2024.
This report reveals other critical factors behind Western Europe’s market shift, helping explain why a dip in inflation isn’t leading to the same growth gains seen elsewhere. Get the full picture with 109 data charts of global sales and market growth, along with context and insights into how you can navigate these markets with confidence.
This email was sent to you by the Informa Markets Division of Informa PLC (Privacy Policy). Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
If you do not wish to receive further information from us, please click here. Alternatively, to contact our data services team to have your details or preferences updated please email imdatateam@informa.com.
